The present invention relates to the use of proinsulin C-peptide or a variant, derivative or fragment thereof in the manufacture of a medicament for reducing the OTc interval and the use of proinsulin C-peptide or a variant, derivative or fragment thereof in the manufacture of a medicament for reducing the risk of sudden death or `dead in bed` syndrome; particularly in patients suffering from IDDM.

 
Web www.patentalert.com

> Isosurface extraction into splat hierarchy

~ 00345